TRPM8 puts the chill on prostate cancer

14Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

Prostate cancer (PCa) is one of the most frequently diagnosed cancers in developed countries. Several studies suggest that variations in calcium homeostasis are involved in carcinogenesis. Interestingly, (Transient Receptor Potential Melastatin member 8) TRPM8 calcium permeable channel expression is differentially regulated during prostate carcinogenesis, thereby suggesting a potential functional role for this channel in those cell processes, which are important for PCa evolution. Indeed, several studies have shown that TRPM8 plays a key role in processes such as the proliferation, viability and cell migration of PCa cells. Where cell migration is concerned, TRPM8 seems to have a protective anti-invasive effect and could be a particularly promising therapeutic target. The goal of this review is to inventory advances in understanding of the role of TRPM8 in the installation and progression of PCa.

Author supplied keywords

Cite

CITATION STYLE

APA

Grolez, G. P., & Gkika, D. (2016, September 1). TRPM8 puts the chill on prostate cancer. Pharmaceuticals. MDPI AG. https://doi.org/10.3390/ph9030044

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free